Speak to the pharma team
01628 581 240
Speak to the healthcare team
01225 336 335
Speak to the clinical team
01628 581 240
Speak to the contract team
01225 336 335
Speak to us about Master Vendor
01225 336 335
Or send your enquiry via email and the best person to help will be in touch.
solutions@starmedical.co.uk
Link Pharmaceuticals acquires and licences niche pharmaceutical products from multinational and development companies. Large multinational companies cannot always prioritise their more unusual products so Link helps them to grow sales by focusing their sales energies and ideas on such products. They also help development companies to enter the UK and European markets.
Companies that have chosen to divest or out-licence their products to Link include:
GlaxoSmithKline
Ethypharm
Pfizer
Aventis
Guilford Pharmaceuticals
Amersham
Zomorph Capsules - for severe pain.
Pabrinex - for treatment of a form of brain damage associated with alcohol withdrawal.
Nozinan - anti-emetic for patients with advanced cancer.
Gliadel Wafer - chemotherapy treatment for brain cancer, applied directly to the brain.
Metastron - radio-isotope treatment for bone pain in advanced prostate cancer.
